Galapagos, NV
Collaboration to pursue small-molecule drug-discovery program in arthritis
Published in Pharma Investments, Ventures and Law Weekly, September 18th, 2005
The collaboration, funded in part by an Innovatiesubsidie Samenwerkingsprojecten grant from the Dutch Ministry of Economic Affairs, brings together three Benelux biotech companies and a Dutch university.
As a member of the collaborative effort, Galapagos will contribute its arthritis disease biology and a validated target for drug development, which has been discovered using its small-interfering RNA-based technologies. ZoBio will be responsible for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Access Pharmaceuticals, Inc.
Pharmaceutical company announces financing arrangement - Actavis
Pharma company appoints chief executive of finance - Acusphere, Inc.
Pharmaceutical firm spends $8.4M to build out facility for drug manufacturing - Adherex Technologies, Inc.
Pharmaceutical firm reports loss of $0.13 per share - Adventrx Pharmaceuticals, Inc.
Pharmaceutical firm posts loss of $0.06 per share - Alder Biopharmaceuticals, Inc.
Biopharmaceutical company raises $11.1M in series A financing - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
